Initiating angiotensin II at lower vasopressor doses in vasodilatory shock: an exploratory post-hoc analysis of the ATHOS-3 clinical trial.
Wieruszewski PM, Bellomo R, Busse LW, Ham KR, Zarbock A, Khanna AK, Deane AM, Ostermann M, Wunderink RG, Boldt DW, Kroll S, Greenfeld CR, Hodges T, Chow JH; Angiotensin II for the Treatment of High-Output Shock 3 (ATHOS-3) Investigators.
Wieruszewski PM, et al. Among authors: khanna ak.
Crit Care. 2023 May 5;27(1):175. doi: 10.1186/s13054-023-04446-1.
Crit Care. 2023.
PMID: 37147690
Free PMC article.
Clinical Trial.